Dean; Michael C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dean; Michael C..The latest application filed is for "lipopeptide inhibitors of ras oncoproteins".

Company Profile

0.14.15

Dean; Michael C. - Frederick MD
Dean; Michael C. - Alpharetta GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of inhibiting ABCG2 and related treatments Grant 9,937,217 - Henrich , et al. April 10, 2	2018-04-10
Lipopeptide Inhibitors Of Ras Oncoproteins App 20160151456 - Tarasova; Nadya I. ; et al.	2016-06-02
Lipopeptide inhibitors of RAS oncoproteins Grant 9,328,142 - Tarasova , et al. May 3, 2	2016-05-03
Method of inhibiting ABCG2 and other treatment methods Grant 9,314,448 - Henrich , et al. April 19, 2	2016-04-19
Method Of Inhibiting Abcg2 And Related Treatments App 20150342978 - Henrich; Curtis J. ; et al.	2015-12-03
Method of inhibiting ABCG2 and related treatments Grant 9,114,102 - Henrich , et al. August 25, 2	2015-08-25
Variants in complement regulatory genes predict age-related macular degeneration Grant 9,063,139 - Allikmets , et al. June 23, 2	2015-06-23
Lipopeptide Inhibitors Of Ras Oncoproteins App 20140135276 - Tarasova; Nadya I. ; et al.	2014-05-15
Method Of Inhibiting Abcg2 And Other Treatment Methods App 20130274323 - Henrich; Curtis J. ; et al.	2013-10-17
Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer Grant 8,470,888 - Henrich , et al. June 25, 2	2013-06-25
Variants in Complement Regulatory Genes Predict Age-Related Macular Degeneration App 20120071356 - Allikmets; Rando L. ; et al.	2012-03-22
Variants in complement regulatory genes predict age-related macular degeneration Grant 8,012,683 - Allikmets , et al. September 6, 2	2011-09-06
Method Of Inhibiting Abcg2 And Other Treatment Methods App 20100317732 - Henrich; Curtis J. ; et al.	2010-12-16
Protective Complement Proteins and Age-Related Macular Degeneration App 20100273720 - Hageman; Gregory S. ; et al.	2010-10-28
Method Of Inhibiting Abcg2 And Related Treatments App 20100267652 - Henrich; Curtis J. ; et al.	2010-10-21
Insulated System for Dispensing a One-Component Polyurethane Foam App 20100219204 - Dean; Michael C. ; et al.	2010-09-02
Protective complement proteins and age-related macular degenration App 20080280825 - Hageman; Gregory S. ; et al.	2008-11-13
Variants in complement regulatory genes predict age-related macular degeneration App 20080261211 - Allikmets; Rando L. ; et al.	2008-10-23
Protective complement proteins and age-related macular degeneration App 20080146501 - Hageman; Gregory S. ; et al.	2008-06-19
Basal cell carcinoma tumor suppressor protein Grant 7,317,086 - Dean , et al. January 8, 2	2008-01-08
ATP-binding transporter (ABC7) and method for detection of Anemia and Ataxia App 20040203073 - Dean, Michael C. ; et al.	2004-10-14
Carton for foam dispensing system Grant 6,564,973 - Brown , et al. May 20, 2	2003-05-20
Carton For Foam Dispensing System App 20030085241 - Brown, Daniel P. ; et al.	2003-05-08
Safety mechanism for dispensing apparatus Grant 6,431,468 - Brown , et al. August 13, 2	2002-08-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.